rs780086745

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM5BP4_StrongBP6BS1BS2

The NM_006517.5(SLC16A2):​c.890G>A​(p.Arg297His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000141 in 1,209,908 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R297L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.000014 ( 0 hom. 9 hem. )

Consequence

SLC16A2
NM_006517.5 missense

Scores

14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.0620

Publications

0 publications found
Variant links:
Genes affected
SLC16A2 (HGNC:10923): (solute carrier family 16 member 2) This gene encodes an integral membrane protein that functions as a transporter of thyroid hormone. The encoded protein facilitates the cellular importation of thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3) and diidothyronine (T2). This gene is expressed in many tissues and likely plays an important role in the development of the central nervous system. Loss of function mutations in this gene are associated with psychomotor retardation in males while females exhibit no neurological defects and more moderate thyroid-deficient phenotypes. This gene is subject to X-chromosome inactivation. Mutations in this gene are the cause of Allan-Herndon-Dudley syndrome. [provided by RefSeq, Mar 2012]
SLC16A2 Gene-Disease associations (from GenCC):
  • Allan-Herndon-Dudley syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chrX-74524672-C-A is described in ClinVar as Pathogenic. ClinVar VariationId is 449964.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.041076183).
BP6
Variant X-74524673-G-A is Benign according to our data. Variant chrX-74524673-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 436738.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.0000137 (15/1098080) while in subpopulation SAS AF = 0.000222 (12/54148). AF 95% confidence interval is 0.000128. There are 0 homozygotes in GnomAdExome4. There are 9 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC16A2NM_006517.5 linkc.890G>A p.Arg297His missense_variant Exon 3 of 6 ENST00000587091.6 NP_006508.2 P36021

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC16A2ENST00000587091.6 linkc.890G>A p.Arg297His missense_variant Exon 3 of 6 1 NM_006517.5 ENSP00000465734.1 P36021
SLC16A2ENST00000590447.1 linkc.329G>A p.Arg110His missense_variant Exon 2 of 4 5 ENSP00000466213.1 K7ELT4
SLC16A2ENST00000636771.1 linkn.*591G>A non_coding_transcript_exon_variant Exon 4 of 7 5 ENSP00000490445.1 A0A1B0GVB4
SLC16A2ENST00000636771.1 linkn.*591G>A 3_prime_UTR_variant Exon 4 of 7 5 ENSP00000490445.1 A0A1B0GVB4

Frequencies

GnomAD3 genomes
AF:
0.0000179
AC:
2
AN:
111775
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000379
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000218
AC:
4
AN:
183261
AF XY:
0.0000443
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000137
AC:
15
AN:
1098080
Hom.:
0
Cov.:
33
AF XY:
0.0000248
AC XY:
9
AN XY:
363442
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26400
American (AMR)
AF:
0.00
AC:
0
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.000222
AC:
12
AN:
54148
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40469
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00000356
AC:
3
AN:
842035
Other (OTH)
AF:
0.00
AC:
0
AN:
46094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000179
AC:
2
AN:
111828
Hom.:
0
Cov.:
22
AF XY:
0.0000588
AC XY:
2
AN XY:
34020
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30761
American (AMR)
AF:
0.00
AC:
0
AN:
10596
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3547
South Asian (SAS)
AF:
0.000380
AC:
1
AN:
2630
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6060
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
215
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53158
Other (OTH)
AF:
0.00
AC:
0
AN:
1530
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 04, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spastic paraplegia Benign:1
Nov 09, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.2
DANN
Benign
0.94
DEOGEN2
Benign
0.40
T
FATHMM_MKL
Benign
0.036
N
LIST_S2
Benign
0.69
T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.041
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L
PhyloP100
-0.062
PrimateAI
Benign
0.26
T
Sift4G
Benign
0.27
T
Polyphen
0.0020
B
Vest4
0.014
MutPred
0.51
Loss of MoRF binding (P = 0.0165);
MVP
0.33
MPC
1.1
ClinPred
0.026
T
GERP RS
-7.7
Varity_R
0.054
gMVP
0.35
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs780086745; hg19: chrX-73744508; API